INNOVUS PHARMACEUTICALS, INC. Proceeds from Warrant Exercises
INNOVUS PHARMACEUTICALS, INC. reported Proceeds from Warrant Exercises of $2.70 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2018-11-14
- INNOVUS PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2016-12-31 was $0.00.
- INNOVUS PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2015-12-31 was $0.00.
- INNOVUS PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2016 was $310.14K.
- INNOVUS PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2015 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|
| 2018-09-30 | $2.70M 10-Q · filed 2018-11-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $310.14K 10-K · filed 2017-03-09 | |
| 2016-09-30 | $310.14K 10-Q · filed 2016-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $0.00 10-K · filed 2017-03-09 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |